3-[(2,6-dichlorophenyl)methyl]-5-(1-methylsulfonylpiperidin-4-yl)-6H-triazolo[4,5-d]pyrimidin-7-one
C17H18Cl2N6O3S — CID 135515886
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(2,6-dichlorophenyl)methyl]-5-(1-methylsulfonylpiperidin-4-yl)-6H-triazolo[4,5-d]pyrimidin-7-one
3-[(2,6-dichlorophenyl)methyl]-5-(1-methylsulfonylpiperidin-4-yl)-6H-triazolo[4,5-d]pyrimidin-7-one (PubChem CID 135515886) has the molecular formula C17H18Cl2N6O3S and a molecular weight of 457.34 g/mol. Its IUPAC name is 3-[(2,6-dichlorophenyl)methyl]-5-(1-methylsulfonylpiperidin-4-yl)-6H-triazolo[4,5-d]pyrimidin-7-one.
Molecular Properties
| Compound Name | 3-[(2,6-dichlorophenyl)methyl]-5-(1-methylsulfonylpiperidin-4-yl)-6H-triazolo[4,5-d]pyrimidin-7-one |
|---|---|
| PubChem CID | 135515886 |
| Molecular Formula | C17H18Cl2N6O3S |
| Molecular Weight | 457.34 g/mol |
| Exact Mass | 456.05 |
| IUPAC Name | 3-[(2,6-dichlorophenyl)methyl]-5-(1-methylsulfonylpiperidin-4-yl)-6H-triazolo[4,5-d]pyrimidin-7-one |
| SMILES | CS(=O)(=O)N1CCC(c2nc3c(nnn3Cc3c(Cl)cccc3Cl)c(=O)[nH]2)CC1 |
| InChI | InChI=1S/C17H18Cl2N6O3S/c1-29(27,28)24-7-5-10(6-8-24)15-20-16-14(17(26)21-15)22-23-25(16)9-11-12(18)3-2-4-13(11)19/h2-4,10H,5-9H2,1H3,(H,20,21,26) |
| InChIKey | ZUXCKFPXIMKGMO-UHFFFAOYSA-N |
| XLogP | 2.01 |
| TPSA | 113.84 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.34 |
| LogP ≤ 5 | 2.01 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135515886 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.